3088 Stock Overview
Operates and manages a chain of drug stores and health insurance prescription pharmacies in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 3088 from our risk checks.
MatsukiyoCocokara & Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,560.00 |
| 52 Week High | JP¥2,694.00 |
| 52 Week Low | JP¥2,022.00 |
| Beta | 0 |
| 1 Month Change | 6.89% |
| 3 Month Change | 12.11% |
| 1 Year Change | 15.73% |
| 3 Year Change | 78.40% |
| 5 Year Change | 110.41% |
| Change since IPO | 930.24% |
Recent News & Updates
MatsukiyoCocokara & Co.'s (TSE:3088) Shareholders Might Be Looking For Exit
Apr 10
Analysts Have Made A Financial Statement On MatsukiyoCocokara & Co.'s (TSE:3088) Third-Quarter Report
Feb 18MatsukiyoCocokara & Co. (TSE:3088) Shares Could Be 26% Below Their Intrinsic Value Estimate
Feb 10Recent updates
MatsukiyoCocokara & Co.'s (TSE:3088) Shareholders Might Be Looking For Exit
Apr 10Analysts Have Made A Financial Statement On MatsukiyoCocokara & Co.'s (TSE:3088) Third-Quarter Report
Feb 18MatsukiyoCocokara & Co. (TSE:3088) Shares Could Be 26% Below Their Intrinsic Value Estimate
Feb 10Is MatsukiyoCocokara (TSE:3088) A Risky Investment?
Jan 10Subdued Growth No Barrier To MatsukiyoCocokara & Co.'s (TSE:3088) Price
Dec 05An Intrinsic Calculation For MatsukiyoCocokara & Co. (TSE:3088) Suggests It's 22% Undervalued
Nov 11Do MatsukiyoCocokara's (TSE:3088) Earnings Warrant Your Attention?
Oct 24MatsukiyoCocokara & Co.'s (TSE:3088) Share Price Could Signal Some Risk
Sep 03MatsukiyoCocokara (TSE:3088) Has A Rock Solid Balance Sheet
Aug 13Are Investors Undervaluing MatsukiyoCocokara & Co. (TSE:3088) By 30%?
Jul 12Does MatsukiyoCocokara (TSE:3088) Deserve A Spot On Your Watchlist?
Jun 15Is MatsukiyoCocokara (TSE:3088) Using Too Much Debt?
Apr 29Shareholder Returns
| 3088 | JP Consumer Retailing | JP Market | |
|---|---|---|---|
| 7D | -1.2% | 0.2% | 2.3% |
| 1Y | 15.7% | 9.2% | -2.0% |
Return vs Industry: 3088 exceeded the JP Consumer Retailing industry which returned 9.1% over the past year.
Return vs Market: 3088 exceeded the JP Market which returned -2% over the past year.
Price Volatility
| 3088 volatility | |
|---|---|
| 3088 Average Weekly Movement | 4.0% |
| Consumer Retailing Industry Average Movement | 4.0% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in JP Market | 9.3% |
| 10% least volatile stocks in JP Market | 3.1% |
Stable Share Price: 3088 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3088's weekly volatility (4%) has been stable over the past year.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 13,371 | Kiyoo Matsumoto | www.matsukiyococokara.com |
MatsukiyoCocokara & Co. operates and manages a chain of drug stores and health insurance prescription pharmacies in Japan. The company is involved in the franchising of its stores. MatsukiyoCocokara & Co. was founded in 1932 and is based in Tokyo, Japan.
MatsukiyoCocokara & Co. Fundamentals Summary
| 3088 fundamental statistics | |
|---|---|
| Market cap | JP¥1.03t |
| Earnings (TTM) | JP¥51.27b |
| Revenue (TTM) | JP¥1.05t |
20.1x
P/E Ratio1.0x
P/S RatioIs 3088 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3088 income statement (TTM) | |
|---|---|
| Revenue | JP¥1.05t |
| Cost of Revenue | JP¥685.96b |
| Gross Profit | JP¥367.76b |
| Other Expenses | JP¥316.48b |
| Earnings | JP¥51.27b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 09, 2025
| Earnings per share (EPS) | 127.05 |
| Gross Margin | 34.90% |
| Net Profit Margin | 4.87% |
| Debt/Equity Ratio | 3.8% |
How did 3088 perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield33%
Payout RatioDoes 3088 pay a reliable dividends?
See 3088 dividend history and benchmarks| MatsukiyoCocokara dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 24 2025 |
| Days until Ex dividend | 30 days |
| Days until Dividend pay date | 58 days |
Does 3088 pay a reliable dividends?
See 3088 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/26 04:46 |
| End of Day Share Price | 2025/04/25 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MatsukiyoCocokara & Co. is covered by 22 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arashi Nishizawa | BofA Global Research |
| Mitsuru Takayanagi | Citigroup Inc |
| Nigel Muston | CLSA |